Related Experiment Videos
An evaluation of a low-density DNA microarray using cytochrome P450 inducers
Georgina Meneses-Lorente1, Françoise de Longueville, Sofia Dos Santos-Mendes
1Merck Sharp & Dohme Neuroscience Research Center, Terling Park, Harlow, Essex, CM20 2QR, United Kingdom. georgina_meneseslorente@merck.com
Chemical Research in Toxicology
|September 16, 2003
Summary
This study validates the Rat HepatoChip, a DNA microarray for assessing drug toxicity. It shows gene expression profiles correlate with liver histopathology, offering a fast tool for drug discovery.
Area of Science:
- Toxicology
- Genomics
- Drug Discovery
Background:
- Assessing drug-induced liver toxicity is crucial in drug development.
- Existing methods can be time-consuming and lack comprehensive gene expression data.
Purpose of the Study:
- To validate the Rat HepatoChip, a novel DNA microarray for toxicological assessment.
- To evaluate its ability to detect gene expression changes related to drug metabolism and toxicity.
Main Methods:
- A low-density DNA microarray (Rat HepatoChip) with 59 genes was designed.
- Liver mRNA was analyzed from rats exposed to various chemicals known to affect cytochrome P450 genes.
- Replicate microarrays were used to assess chip and process variability.
Main Results:
- The Rat HepatoChip demonstrated an average signal variability of 33% across triplicate experiments.
- A strong correlation was observed between liver histopathology and gene expression profiles.
- The gene expression profile accurately reflected histopathological changes.
Conclusions:
- The Rat HepatoChip is a validated tool for assessing drug toxicity.
- It provides a rapid and effective method for evaluating the toxicity profiles of drug candidates.
- This microarray can aid in streamlining the drug discovery process.